Bears are piling into VALE, but the options market isn't buying it. Short shares jumped 25% in a month. Yet put/call positioning tells a different story.
Short shares in VALE have climbed from 55.3M on April 9 to 69.5M on May 4. That's a 25.7M share increase in under four weeks. The one-month change stands at +24.9%.
The narrative driving the build is familiar: China demand headwinds, falling iron ore shipments, and a stock down 7.2% over the past week. Barclays downgraded the stock from Overweight to Equal-Weight on April 20, and Wells Fargo lowered its price target to $16 last week.
The borrow market, however, remains wide open. Availability is extremely loose — the 52-week peak utilization was just 26%, and current levels sit near 1.4%. Bears have no problem sourcing shares. There's no squeeze dynamic here.
The put/call ratio sits at 1.12 as of May 4. That sounds bearish on the surface. But it's close to the 20-day mean of 1.10, and a week earlier it briefly dropped near 1.03 — nearly two standard deviations below that mean. Options traders dipped toward their most bullish positioning in months, even as short sellers were adding exposure.
That divergence is the tension at the heart of this setup. Short sellers are expressing a macro view on iron ore and China. Options traders are hedging more cautiously, and at moments have been actively fading the bearish thesis.
Analyst opinion is split, and the recent moves reflect that tension precisely.
Morgan Stanley holds a $19.50 target with an Overweight rating. JP Morgan is at $18.50, also Overweight. Bank of America upgraded to Buy in early April with a $19 target.
Then the mood shifted. Barclays cut the stock to Equal-Weight. Wells Fargo followed with a target trim to $16, one dollar above where the stock trades today.
The consensus is Hold. The mean target is $17.18 — 8.5% above the current price of $15.84. Bulls see free cash flow recovery and iron ore diversification away from China. Bears point to declining shipments to China, which fell from 65% of volumes in 2021 to 61% in 2024, with projections showing a further drop to 54% by 2030.
Cost to borrow rose 78% week-on-week to 0.43% APR. In absolute terms that's still cheap. But the direction matters. CTB was as low as 0.24% in late April. The recent drift upward, coinciding with the short interest build, suggests incremental demand for borrows — even if supply is plentiful.
The ORTEX short score stands at 30.9. That's not extreme. The next earnings event is July 30.
What to watch: Whether the options PCR drifts back toward put-heavy territory — or holds near the 20-day mean while shorts continue to build — will signal which camp is gaining conviction.
See the live data behind this article on ORTEX.
Open VALE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
